洞察市场格局
解锁药品研发情报

客服电话

400-9696-311

医药数据查询

【ChiCTR-IPR-17013088】Clinical study of localized Tui Na combination with points press in reducing the symptoms of knee stiffness in Parkinson's disease: A Randomized Pilot Clinical Trial

查看原文

立即下载

基本信息

登记号

ChiCTR-IPR-17013088

试验状态

尚未开始

药物名称

药物类型

规范名称

首次公示信息日的期

2017-10-23

临床申请受理号

靶点

适应症

帕金森氏病

试验通俗题目

Clinical study of localized Tui Na combination with points press in reducing the symptoms of knee stiffness in Parkinson's disease: A Randomized Pilot Clinical Trial

试验专业题目

Clinical study of localized Tui Na combination with points press in reducing the symptoms of knee stiffness in Parkinson 's disease: A Randomized Pilot Clinical Trial

申办单位信息

申请人联系人

请登录查看

申请人名称

请登录查看

联系人邮箱

请登录查看

联系人邮编

联系人通讯地址

请登录查看

临床试验信息

试验目的

i. To evaluate the efficacy of localized Tui Na combining with points press (Abbreviated as LTNCPP) in reducing the motor symptoms of PD especially focusing on releasing lower limbs movement barriers and muscles dysfunction; ii. To evaluate the safety of LTNCPP in subjects with idiopathic PD in a randomized clinical trial.

试验分类

请登录查看

试验类型

随机平行对照

试验分期

探索性研究/预试验

随机化

A random number sequence will be generated with computer by Co-investigator (Co II), kept in a sealed envelope, and sent to Viven Law in Hong Kong.

盲法

试验项目经费来源

Student Honors Project Funding

试验范围

目标入组人数

实际入组人数

第一例入组时间

2017-04-01

试验终止时间

2018-01-31

是否属于一致性

入选标准

Patients will be included if they have all the following: 1. Meet UKPDBB criteria; 2. Age of 18 to 80 years (inclusive); 3. have the symptoms of LLMB; 4. Stable treatment with levodopa, alone or in combination with other antiparkinsonian drugs or any other treatment over the last 2 months; 5. does not have any bone fractures or operation history over last half year.；

排除标准

Patients will be excluded if they have one or more of the following: 1. Atypical or secondary Parkinsonism; 2. with any other severe diseases (i.e. cancer and acute present asthma); 3. operation history or trauma history over last half year; 4. Pregnancy or are breast feeding.；

研究者信息

研究负责人姓名

请登录查看

试验机构

香港浸會大學中醫藥學院

研究负责人电话

请登录查看

研究负责人邮箱

请登录查看

研究负责人邮编

联系人通讯地址

请登录查看